Kardigan, Inc. (KARD)
21.92
+2.32
(+11.84%)
USD |
NASDAQ |
Sep 02, 16:00
21.88
-0.04
(-0.18%)
After-Hours: 20:00
Kardigan Price to Book Value : 3.329 for Sept. 2, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 02, 2026 | 3.329 |
| September 01, 2026 | 2.976 |
| August 31, 2026 | 3.061 |
| August 28, 2026 | 3.040 |
| August 27, 2026 | 3.158 |
| August 26, 2026 | 3.216 |
| August 25, 2026 | 3.177 |
| August 24, 2026 | 3.134 |
| August 21, 2026 | 3.192 |
| August 20, 2026 | 3.076 |
| August 19, 2026 | 3.342 |
| August 18, 2026 | 3.177 |
| August 17, 2026 | 3.120 |
| August 14, 2026 | 3.067 |
| August 13, 2026 | 3.312 |
| August 12, 2026 | 3.307 |
| August 11, 2026 | 3.350 |
| August 10, 2026 | 3.201 |
| August 07, 2026 | 3.113 |
| August 06, 2026 | 3.092 |
| August 05, 2026 | 3.075 |
| August 04, 2026 | 3.111 |
| August 03, 2026 | 3.032 |
| Date | Value |
|---|---|
| July 31, 2026 | 3.162 |
| July 30, 2026 | 3.108 |
| July 29, 2026 | 2.996 |
| July 28, 2026 | 3.187 |
| July 27, 2026 | 3.224 |
| July 24, 2026 | 3.149 |
| July 23, 2026 | 3.291 |
| July 22, 2026 | 3.471 |
| July 21, 2026 | 3.479 |
| July 20, 2026 | 3.250 |
| July 17, 2026 | 3.209 |
| July 16, 2026 | 3.192 |
| July 15, 2026 | 3.339 |
| July 14, 2026 | 3.380 |
| July 13, 2026 | 3.573 |
| July 10, 2026 | 3.741 |
| July 09, 2026 | 3.713 |
| July 08, 2026 | 3.374 |
| July 07, 2026 | 3.619 |
| July 06, 2026 | 3.611 |
| July 02, 2026 | 3.698 |
| July 01, 2026 | 3.661 |
| June 30, 2026 | 3.622 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.800 |
| Bristol Myers Squibb Co. | 6.193 |
| Crinetics Pharmaceuticals, Inc. | 7.541 |
| ANI Pharmaceuticals, Inc. | 2.810 |
| Corcept Therapeutics, Inc. | 16.89 |
Price to Book Value Related Metrics
| Price | 21.92 |
| Earnings Yield | -12.39% |
| Market Cap | 2.049B |